Namyang Dairy chairman under cost pressure after losing cases against Hahn & Co Hong Won-sik has to pay PE firm’s legal costs and refund prepayment to former partner
Translated by Ryu Ho-joung 공개 2022-03-17 08:11:52
이 기사는 2022년 03월 17일 07:57 thebell 에 표출된 기사입니다.
Hong Won-sik, chairman of South Korea’s Namyang Dairy Products, has lost again in court with his case against Hahn & Company, putting him under greater financial pressure in a long-running legal battle with the Seoul-based private equity firm.On Tuesday, the Seoul Central District Court dismissed a case brought by Hong in January seeking to overturn the court’s decision that sided with Hahn & Co and prevented the chairman and his family members from selling their controlling stake to Dayou Winia Group.
Hong, who last spring signed a deal to sell his firm to Hahn & Co, abruptly announced a conditional agreement with Dayou Winia in November. In response, the private equity firm filed an injunction to block the share sale on December 3 and the court accepted Hahn & Co’s request on January 26. But Hong refused to accept the decision and filed an objection with the court on the following day.
The court’s recent decision comes on the same day Dayou Winia announced that its deal with the dairy firm is no longer valid as of March 7, citing the counterparty’s violation of terms of conditions as the reason for the cancellation.
Hong appears to be under increasing financial pressure as the legal fight continues. He lost all injunction suits against Hahn & Co, obligating him to pay legal fees and costs to the private equity firm. This could be a big burden for him, especially when the main case is still ongoing and is expected to take years to resolve.
Moreover, Hong needs to refund a 35 billion won prepayment to Dayou Winia as the deal terminated. Dayou Winia had originally agreed to buy 378,938 shares in Namyang Dairy owned by Hong and his wife and grandson for about 320 billion won.
“We cannot confirm whether chairman Hong already refunded the prepayment,” a Dayou Winia official said. (Reporting by Gyoung-tae Kim)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [제일약품의 온코닉테라퓨틱 첫 '신약']세번째 P-CAB '자큐보' 2년만에 신약 명맥 잇는다
- 강동그룹, 디아너스CC 품는다
- [제약사 TSR 분석]제일약품, '주가·실적·배당' 3중고 열쇠 '온코닉의 신약'
- (여자)아이들 우기, 'YUQ1' 아이튠즈 앨범차트 10개국 석권
- 박셀바이오, 진행성 간세포암 타깃 'Vax-NK' 특허 출원
- 베니스 비엔날레, 30년만에 두발로 선 '곽훈'의 의미
- [대기업 프로스포츠 전술전략]'모기업발 숙제' 엔씨다이노스, 당분간 긴축 불가피
- 하이브, '민희진 없는' 어도어 경쟁력 입증할까
- SK 오너가 3세 최성환의 '승부수'
- 어느 수집가의 꿈 '이건희 컬렉션'